- Home
- Scans for Women
- Scans for Men
- Msk
- Pregnancy
- Cardiovascular
- About
- Book a Scan
- Blog
If a close relative has been diagnosed with a heart condition — or died suddenly from a cardiac event — your own risk may be significantly elevated. Family history heart screening with a diagnostic echocardiogram can identify inherited cardiac conditions before symptoms develop, enabling early intervention that is often life-saving.
Learning that heart disease runs in your family can be deeply unsettling. Whether you have just discovered a parent's diagnosis, or you have been carrying the weight of a family history of sudden cardiac death for years, the uncertainty about your own heart health is a heavy burden. You may have been told to "keep an eye on things" by your GP, or found yourself waiting months for an NHS cardiology appointment — all while wondering whether your heart is structurally sound.
At Sonoworld Diagnostic Services, our consultant sonographers bring over 20 years of NHS and private clinical experience to every cardiac assessment. We provide same-day echocardiogram appointments in London without the need for a GP referral, delivering detailed written reports within 24 hours. Every assessment is conducted in strict accordance with NICE CG180, ESC 2023 Cardiomyopathy Guidelines, and ESC 2021 Prevention Guidelines.
Secure online booking · Results within 24 hours · Insurance accepted (AXA, Healix, WPA)
In clinical practice, a significant family history of heart disease is defined as a first-degree relative — a parent, sibling, or child — who has been diagnosed with a cardiac condition or who died suddenly from a cardiac event. The degree of risk depends on the specific condition, the age at which it occurred, and the number of affected relatives.
The landmark INTERHEART study — one of the largest cardiovascular epidemiology studies ever conducted, with over 11,000 citations — identified family history as one of nine independent risk factors accounting for more than 90% of global myocardial infarction risk.1 Clinically, "premature" cardiovascular disease is defined as a heart attack or coronary artery disease diagnosis in a male first-degree relative under the age of 55, or a female first-degree relative under 65. Individuals with this family history carry a 2–3 times increased risk of developing coronary artery disease themselves.
Beyond the absolute risk increase, a 2025 study in Circulation demonstrated that adding a 12-SNP polygenic risk score to the PREVENT clinical risk equation increased predictive accuracy (Harrell's C statistic from 0.747 to 0.757, p<0.0001), with a Net Reclassification Improvement of 10.7 in borderline-risk individuals — directly influencing statin initiation decisions.8 This means genetic risk information now has a measurable clinical impact on preventive treatment thresholds.
Beyond premature coronary artery disease, a separate and critically important category of risk comes from inherited cardiac conditions — structural or electrical abnormalities of the heart that are passed directly from parent to child through autosomal dominant inheritance. These include hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), arrhythmogenic cardiomyopathy (ARVC), Long QT syndrome, Brugada syndrome, and familial hypercholesterolaemia (FH). Unlike lifestyle-related heart disease, these conditions can affect young, otherwise healthy individuals and carry a risk of sudden cardiac death (SCD).
If a first-degree relative (parent, sibling, or child) suffered a sudden unexplained death under the age of 40, or was diagnosed with an inherited cardiac condition such as HCM, Long QT syndrome, or Brugada syndrome, you should seek a cardiac screening assessment immediately. These conditions are autosomal dominant — each first-degree relative carries a 50% chance of inheriting the causative gene variant. Do not wait for symptoms to develop. The majority of individuals with inherited cardiac conditions are asymptomatic until a potentially fatal arrhythmia or structural event occurs.
The following six inherited cardiac conditions are the most clinically significant from a cardiac family screening perspective. Each carries a defined inheritance pattern and a measurable risk to first-degree relatives — all are detectable or monitorable using echocardiography.
The most common inherited heart muscle disease in the UK. The left ventricular wall becomes abnormally thickened (hypertrophied), impairing diastolic filling and, in 70% of cases, causing left ventricular outflow tract obstruction (LVOTO). HCM is the leading cause of sudden cardiac death in young athletes. First-degree relatives have a 50% chance of inheriting the causative gene variant.3 Learn more about cardiomyopathy types and how they are inherited.
The left ventricle becomes enlarged (dilated) and the myocardium weakens, reducing the ejection fraction and the heart's ability to pump blood effectively. Approximately 30–50% of DCM cases have a genetic basis, with over 50 causative genes identified. Genetic screening of first-degree relatives identifies preclinical disease in a significant proportion of asymptomatic family members. Understand your ejection fraction and what it means.
The right ventricular muscle is progressively replaced by fibrous or fatty tissue (fibrofatty replacement), creating an arrhythmogenic substrate for life-threatening ventricular arrhythmias. ARVC is responsible for a disproportionate number of sudden cardiac deaths in young people and athletes. Echocardiography assesses right ventricular dilation, reduced RV function, and RV aneurysm formation.
These are inherited channelopathies — electrical disorders of the heart in which the cardiac structure appears normal on echocardiogram, but the ion channel function is abnormal. Long QT syndrome prolongs ventricular repolarisation, predisposing to Torsades de Pointes. Brugada syndrome causes a characteristic coved ST-elevation pattern on ECG and a risk of ventricular fibrillation, particularly during sleep or fever. ECG is the primary diagnostic tool; echocardiogram excludes structural disease.
FH affects approximately 1 in 250 people in the UK, yet the vast majority remain undiagnosed (NICE CG71). It causes markedly elevated LDL cholesterol from birth, dramatically accelerating the development of premature coronary artery disease. A 2025 study of 1,886 FH patients found that those with a high polygenic risk score had a 1.92-fold increased risk of cardiovascular events (HR 1.92, 95% CI 1.55–2.37, p<0.0001).4
The most common congenital heart defect, affecting 1–2% of the general population. However, first-degree relatives of a BAV patient have a 9.1% prevalence — nearly five times higher than the general population.5 BAV is associated with progressive aortic root dilation and an increased risk of aortic dissection, making screening echocardiography essential for at-risk family members. Read more about aortic valve disease and its diagnosis.
The following criteria, drawn from NICE CG180, ESC 2023 Cardiomyopathy Guidelines, and ESC 2021 Prevention Guidelines, define who should be offered a cardiac screening echocardiogram based on their family history. If you meet any of these criteria, you can book directly at Sonoworld without a GP referral.
| Condition in Family | Who Should Be Screened | Age to Start | Frequency |
|---|---|---|---|
| Hypertrophic Cardiomyopathy (HCM) | All first-degree relatives (parents, siblings, children) | From age 10–12 (or earlier if symptomatic) | Every 1–5 years depending on age and findings |
| Dilated Cardiomyopathy (DCM) | All first-degree relatives | From age 10 (or at time of proband diagnosis) | Every 3–5 years if initially normal |
| Arrhythmogenic Cardiomyopathy (ARVC) | All first-degree relatives | From age 10–12 | Every 2–3 years |
| Sudden Cardiac Death under 40 | All first-degree relatives; consider second-degree relatives | Immediately upon discovery of family history | Specialist-guided, with genetic testing |
| Bicuspid Aortic Valve (BAV) | All first-degree relatives | Any age; prioritise adults over 30 | Every 3–5 years if aortic root normal |
| Premature CAD (men <55, women <65) | First-degree relatives from age 20 | From age 20 (earlier if additional risk factors present) | Every 3–5 years with cardiovascular risk assessment |
An echocardiogram — an ultrasound-scan of the heart — is the first-line investigation recommended by NICE and the ESC for all suspected inherited cardiac conditions. It provides a real-time, radiation-free assessment of the heart's structure and function, enabling our consultant sonographers to identify the specific structural changes associated with each inherited condition.
Your cardiac screening echocardiogram at Sonoworld takes approximately 45–60 minutes. You will lie on a comfortable examination couch while our consultant sonographer applies a small amount of warm gel to your chest and uses a handheld transducer to capture images of your heart from multiple angles — parasternal, apical, subcostal, and suprasternal views.
The scan is completely painless and uses no ionising radiation. You will be able to see your heart beating on the monitor in real time. Our sonographer will explain the key findings during the scan, and a full written report will be available within 24 hours — ready to share with your GP, cardiologist, or specialist inherited cardiac conditions (ICC) clinic.
No preparation is required. You can eat and drink normally beforehand, and there is no need to stop any medications prior to the scan.
Same-day appointments available · No GP referral required · From £290
Every cardiac screening echocardiogram performed at Sonoworld is conducted in accordance with the highest clinical and regulatory standards. Our practice is registered with the Care Quality Commission (CQC) and all clinical staff hold current HCPC registration. Our consultant sonographers are members of the British Medical Ultrasound Society (BMUS) and adhere to British Society of Echocardiography (BSE) minimum dataset standards for all cardiac reporting.
Our echocardiogram report provides a detailed structural assessment and will clearly indicate when specialist cardiology review is required. If our scan identifies features consistent with HCM, DCM, ARVC, significant aortic root dilation, or bicuspid aortic valve, we will provide a written recommendation for onward referral to a specialist inherited cardiac conditions (ICC) clinic. We can send a copy of the report directly to your GP or cardiologist to facilitate rapid onward care.
For patients with a confirmed ICC diagnosis, we also provide follow-up echocardiogram surveillance at clinically appropriate intervals in line with guideline recommendations.
For individuals with a family history of premature coronary artery disease, stroke, or familial hypercholesterolaemia, a comprehensive cardiovascular risk assessment may also include a vascular stroke screening — a carotid artery ultrasound-scan that assesses intima-media thickness and identifies early atherosclerotic plaque formation. This is particularly relevant for individuals with multiple cardiovascular risk factors or a strong family history of premature vascular disease.
It depends on the age at which your parent had their heart attack. If your father had a heart attack before the age of 55, or your mother before 65, this is classified as premature coronary artery disease and represents a significant independent risk factor for your own cardiovascular health. A cardiac screening echocardiogram can assess your heart's current structural health, whilst a cardiovascular risk assessment (including blood pressure, cholesterol, and blood glucose) will quantify your overall risk. We recommend booking a private echocardiogram at Sonoworld if you are concerned about NHS waiting times.
HCM is diagnosed when the maximum left ventricular wall thickness is ≥15mm in the absence of another cause (such as hypertension or aortic stenosis). In individuals with a confirmed family history of HCM, a lower diagnostic threshold of ≥13mm is applied. Our consultant sonographers measure wall thickness at multiple points using M-mode and 2D echocardiography, and also assess the left ventricular outflow tract for obstruction (LVOTO) using continuous-wave Doppler, which is present in approximately 70% of HCM patients.
A normal echocardiogram significantly reduces the likelihood of a structural inherited cardiac condition such as HCM, DCM, or ARVC. However, it cannot exclude inherited channelopathies such as Long QT syndrome or Brugada syndrome, which require a 12-lead ECG for diagnosis. Additionally, for conditions like HCM, a normal echocardiogram in a young person (under 18) does not exclude future development of the condition — which is why repeat surveillance scans every 1–5 years are recommended for first-degree relatives of HCM probands throughout adolescence and into adulthood.
We offer same-day and next-day appointments at our London clinic. No GP referral is required — you can book directly online or by telephone. Your written report will be available within 24 hours of your appointment, and we can send a copy directly to your GP or cardiologist upon request. We accept private health insurance from AXA, Healix, WPA, and other major providers. Pricing starts from £290 for a standard echocardiogram.
Tap to Call